The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.